GenScript is a world leader in biotechnology reagent services, providing life sciences services and products to over 100 countries worldwide. Established in 2002 in the United States, the company was one of the first to commercialize gene synthesis and has become an internationally recognized leading biotech company providing life science services and products worldwide. Currently, GenScript has established fully integrated capabilities for custom peptide synthesis, recombinant protein expression and engineering, genome editing, as well as antibody and preclinical drug development services.
As of June 2021, more than 64,700 peer-reviewed journal articles cited GenScript’s services and products, making GenScript the most frequently cited biotech company in the world.
